NUVL Q2 2024 Earnings — Nuvalent, Inc. Revenue & Financial Results | Market Cap Arena

NUVLNuvalent, Inc.

$8B

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$65M

Net Income

-$57M

EPS (Diluted)

$-0.88

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$41M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$675M

Total Liabilities

$38M

Stockholders' Equity

$637M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$65M	-$34M	-91.3%
Net Income	-$57M	-$29M	-96.5%